276 related articles for article (PubMed ID: 31195177)
1. Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.
Giaj-Levra N; Giaj-Levra M; Durieux V; Novello S; Besse B; Hasan B; Hendriks LE; Levy A; Dingemans AC; Berghmans T;
J Thorac Oncol; 2019 Dec; 14(12):2053-2061. PubMed ID: 31195177
[TBL] [Abstract][Full Text] [Related]
2. Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.
Dingemans AC; Hendriks LEL; Berghmans T; Levy A; Hasan B; Faivre-Finn C; Giaj-Levra M; Giaj-Levra N; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Smit EF; Van Schil P; Postmus PE; Ramella S; Lievens Y; Gaga M; Peled N; Scagliotti GV; Senan S; Paz-Ares L; Guckenberger M; McDonald F; Ekman S; Cufer T; Gietema H; Infante M; Dziadziuszko R; Peters S; Porta RR; Vansteenkiste J; Dooms C; de Ruysscher D; Besse B; Novello S
J Thorac Oncol; 2019 Dec; 14(12):2109-2119. PubMed ID: 31398540
[TBL] [Abstract][Full Text] [Related]
3. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
Levy A; Hendriks LEL; Berghmans T; Faivre-Finn C; GiajLevra M; GiajLevra N; Hasan B; Pochesci A; Girard N; Greillier L; Lantuéjoul S; Edwards J; O'Brien M; Reck M; Besse B; Novello S; Dingemans AC;
Eur J Cancer; 2019 Nov; 122():109-114. PubMed ID: 31671363
[TBL] [Abstract][Full Text] [Related]
4. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.
Hendriks LEL; Dooms C; Berghmans T; Novello S; Levy A; De Ruysscher D; Hasan B; Giaj Levra M; Giaj Levra N; Besse B; Vansteenkiste J; Dingemans AC;
Eur J Cancer; 2019 Dec; 123():28-35. PubMed ID: 31655358
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.
Gobbini E; Bertolaccini L; Giaj-Levra N; Menis J; Giaj-Levra M
Transl Lung Cancer Res; 2021 Jul; 10(7):3339-3350. PubMed ID: 34430371
[TBL] [Abstract][Full Text] [Related]
6. Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.
Miyawaki T; Wakuda K; Kenmotsu H; Miyawaki E; Mamesaya N; Kobayashi H; Omori S; Ono A; Naito T; Murakami H; Notsu A; Mori K; Harada H; Endo M; Ohde Y; Takahashi K; Takahashi T
Cancer Sci; 2021 Jan; 112(1):359-368. PubMed ID: 33098119
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of patients with synchronous oligometastatic non-small cell lung cancer in the immunotherapy era: Analysis of a real-life intention-to-treat population.
Jongbloed M; Bartolomeo V; Steens M; Dursun S; van de Lisdonk T; De Ruysscher DKM; Hendriks LEL
Eur J Cancer; 2023 Sep; 190():112947. PubMed ID: 37451182
[TBL] [Abstract][Full Text] [Related]
9. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
10. Evolution of treatment strategies for oligometastatic NSCLC patients - A systematic review of the literature.
Schanne DH; Heitmann J; Guckenberger M; Andratschke NHJ
Cancer Treat Rev; 2019 Nov; 80():101892. PubMed ID: 31522079
[TBL] [Abstract][Full Text] [Related]
11. Routine preoperative brain CT in resectable non-small cell lung cancer - Ten years experience from a tertiary UK thoracic center.
Matys T; Drury R; David S; Rassl DM; Qian W; Rintoul RC; Screaton NJ
Lung Cancer; 2018 Aug; 122():195-199. PubMed ID: 30032831
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
13. Defining Oligometastatic Bladder Cancer: A Systematic Review.
Bamias A; Stenzl A; Zagouri F; Andrikopoulou A; Hoskin P
Eur Urol Open Sci; 2023 Sep; 55():28-37. PubMed ID: 37662704
[TBL] [Abstract][Full Text] [Related]
14. [Radiotherapy for oligometastatic non-small cell lung cancer patients].
Levy A; Roux C; Mercier O; Issard J; Botticella A; Barlesi F; Le Péchoux C
Cancer Radiother; 2021 Oct; 25(6-7):517-522. PubMed ID: 34175225
[TBL] [Abstract][Full Text] [Related]
15. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature.
Ashworth A; Rodrigues G; Boldt G; Palma D
Lung Cancer; 2013 Nov; 82(2):197-203. PubMed ID: 24051084
[TBL] [Abstract][Full Text] [Related]
16. Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.
Arrieta O; Barrón F; Maldonado F; Cabrera L; Corona-Cruz JF; Blake M; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; García O; Arén O; De la Garza J
Lung Cancer; 2019 Apr; 130():67-75. PubMed ID: 30885354
[TBL] [Abstract][Full Text] [Related]
17. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
[TBL] [Abstract][Full Text] [Related]
18. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis.
Spaggiari L; Bertolaccini L; Facciolo F; Gallina FT; Rea F; Schiavon M; Margaritora S; Congedo MT; Lucchi M; Ceccarelli I; Alloisio M; Bottoni E; Negri G; Carretta A; Cardillo G; Ricciardi S; Ruffini E; Costardi L; Muriana G; Viggiano D; Rusca M; Ventura L; Marulli G; De Palma A; Rosso L; Mendogni P; Crisci R; De Vico A; Maniscalco P; Tamburini N; Puma F; Ceccarelli S; Voltolini L; Bongiolatti S; Morelli A; Londero F
Lung Cancer; 2021 Apr; 154():29-35. PubMed ID: 33610120
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and management of oligometastatic non-small cell lung cancer.
Patel AN; Simone CB; Jabbour SK
Ther Adv Respir Dis; 2016 Aug; 10(4):338-48. PubMed ID: 27060187
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of node-negative oligometastatic non-small cell lung cancer.
Sakai K; Takeda M; Hayashi H; Tanaka K; Okuda T; Kato A; Nishimura Y; Mitsudomi T; Koyama A; Nakagawa K
Thorac Cancer; 2016 Nov; 7(6):670-675. PubMed ID: 27755813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
